Skip to main content

Antifilarial activity of a synthetic marine alkaloid, aplysinopsin (CDRI Compound 92/138)

Buy Article:

$51.00 plus tax (Refund Policy)


CDRI Compound 92/138, a synthetic analogue of aplysinopsin, was evaluated in experimental filarial infections, Litomosoides carinii in cotton rats (Sigmodon hispidus) and Acanthocheilonema viteae in Mastomys coucha. The compound killed 63.8 and 90% of adult L. carinii and A. viteae at doses of 30 and 50 mg/kg (i.p.) respectively given for 5 days. By the oral route, at 100 mg/kg for 5 days the compound caused 50.9 and 57% mortality of adult L. carinii and A. viteae, respectively. At 200 mg/kg administered orally on days 0, 10 and 25 post‐infection, it reduced establishment of adult A. viteae by 68.5%. We also found 43.7 and 37.8% effect in vivo respectively on L3 and L4 stages of A. viteae at a single dose of 250 mg/kg, p.o. The compound was active in vitro at 100 g/ml concentration and caused a significant decline in MTT reduction and 14C‐glucose uptake by adult filariids. Thus synthetic marine aplysinopsin could provide a new pharmacophore for the development of antifilarial agents.

Keywords: A. viteae; L. carinii; antifilarial; aplysinopsin

Document Type: Original Article


Affiliations: 1: Division of Parasitology, Central Drug Research Institute, Lucknow, India, 2: Division of Medicinal Chemistry, Central Drug Research Institute, Lucknow, India

Publication date: June 1, 1997


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more